Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases
Taiwo Samuel Agidigbi(Yale University), Chaekyun Kim(Inha University)
Cited by 491
Related Papers
ERK Inhibition Increases RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells by Stimulating AMPK Activation and RANK Expression and Inhibiting Anti-Osteoclastogenic Factor Expression
|International Journal of Molecular Sciences|2022|19